BioLine RX Ltd - ADR (BLRX) stock is lower by -77.58% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives BLRX stock a score of 29 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 1. BLRX's rank also includes a short-term technical score of 16. BLRX has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on BLRX!